- Home
- RUBI vs BMRA Comparison
RUBI vs BMRA Comparison
Compare RUBI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUBI
- BMRA
- Stock Information
- Founded
- RUBI N/A
- BMRA 1971
- Country
- RUBI Marshall Islands
- BMRA United States
- Employees
- RUBI N/A
- BMRA N/A
- Industry
- RUBI Marine Transportation
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RUBI Consumer Discretionary
- BMRA Health Care
- Exchange
- RUBI Nasdaq
- BMRA Nasdaq
- Market Cap
- RUBI 8.9M
- BMRA 7.6M
- IPO Year
- RUBI N/A
- BMRA N/A
- Fundamental
- Price
- RUBI $2.50
- BMRA $2.85
- Analyst Decision
- RUBI
- BMRA
- Analyst Count
- RUBI 0
- BMRA 0
- Target Price
- RUBI N/A
- BMRA N/A
- AVG Volume (30 Days)
- RUBI 439.6K
- BMRA 2.4M
- Earning Date
- RUBI 01-01-0001
- BMRA 10-14-2025
- Dividend Yield
- RUBI N/A
- BMRA N/A
- EPS Growth
- RUBI N/A
- BMRA N/A
- EPS
- RUBI N/A
- BMRA N/A
- Revenue
- RUBI N/A
- BMRA $5,311,000.00
- Revenue This Year
- RUBI N/A
- BMRA N/A
- Revenue Next Year
- RUBI N/A
- BMRA N/A
- P/E Ratio
- RUBI N/A
- BMRA N/A
- Revenue Growth
- RUBI N/A
- BMRA N/A
- 52 Week Low
- RUBI $2.32
- BMRA $2.08
- 52 Week High
- RUBI $6.69
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- RUBI N/A
- BMRA 38.94
- Support Level
- RUBI N/A
- BMRA $2.80
- Resistance Level
- RUBI N/A
- BMRA $3.60
- Average True Range (ATR)
- RUBI 0.00
- BMRA 0.36
- MACD
- RUBI 0.00
- BMRA -0.03
- Stochastic Oscillator
- RUBI 0.00
- BMRA 10.26
About RUBI Rubico Inc. Common Stock
Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.